NS

Nidhi Sharma

Active Director Designated Partner DIN 09209701
DIN 09209701 First appointment Jun 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Nidhi Sharma

Data last updated:

Nidhi Sharma is a Designated Partner at Genbiotex Pharma Llp (since 2021). The company operates in Chemicals.

DIN 09209701
Primary Designation Designated Partner
Industry Chemicals
First Appointment 21 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jun 20212021Active

Board colleagues of Nidhi Sharma

NameDINCompanyDesignation
Daruk Dinesh Lulla09195661Genbiotex Pharma LlpDesignated Partner
Preeti Dinesh Lulla01901930Genbiotex Pharma LlpDesignated Partner
Sanjay Sharma09209700Genbiotex Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Genbiotex Pharma Llp
Premium access

Shareholding and investment profile for Nidhi Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nidhi Sharma

Nidhi Sharma currently holds 1 directorship: Genbiotex Pharma Llp (Designated Partner, since 21 Jun 2021).

Nidhi Sharma was first appointed on 21 Jun 2021 as Designated Partner at Genbiotex Pharma Llp.

The current boards of Nidhi Sharma's companies include Daruk Dinesh Lulla (Genbiotex Pharma Llp), Preeti Dinesh Lulla (Genbiotex Pharma Llp), Sanjay Sharma (Genbiotex Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available